Cancer survivors' stories: An African perspective

ESMO 2022: Breast and ovarian trial analysis

ESMO 2022: Highlights, commentary and analysis

A new era of early cancer detection with blood test may change cancer screening paradigms

New era of early cancer detection blood tests on the horizon

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

New data presented at ESMO for multi-cancer early detection

Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer

Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem

Working to improve global cancer care access in low middle-income countries

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes